ArticleScientific reports2026
Gastrointestinal malignancy in iron deficiency without anemia: a retrospective study from Jordan.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Iron deficiency without anemia: An underrecognized and undertreated clinical condition with special focus on colorectal cancer.Clinical hematology international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guidelines clearly recommend endoscopic investigation for iron deficiency anemia but are ambiguous for iron deficiency without anemia. We aimed to compare gastrointestinal malignancy rates between patients with iron deficiency without anemia and iron deficiency anemia, and to identify factors associated with malignancy. We performed a retrospective cohort study of adult patients who underwent bidirectional endoscopic examination for iron deficiency (ferritin levels < 45 µg/l) at two major Jordanian hospitals over 1.5 years. The total cohort consisted of 480 patients and was divided into two groups: iron deficiency anemia (274 patients) and iron deficiency without anemia (206 patients). Patients with iron deficiency anemia were significantly older (mean age 56.0 vs. 52.2 years, p = 0.007) and included a higher proportion of females (68.2% vs. 57.8%, p = 0.018). There was no significant difference in the rate of gastrointestinal malignancy between patients with anemia (1.8%) and those without anemia (2.4%), with an overall prevalence of malignancy of 2.1%. Colorectal adenocarcinoma was the most common malignancy (7 out of 10 cases). Notably, all gastric malignancies (3 cases) occurred in patients without anemia. Increasing age emerged as the only significant predictor of malignancy. These preliminary findings suggest that endoscopic evaluation may be considered for all patients with iron deficiency, regardless of anemia status, particularly for older patients. Larger prospective studies are needed to clarify the true risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.